Research
Topics:
INDEX
AI-chat 5
PRIME 22
aging 12
brain 10
brainwave 1
cancer 8
climate 2
cognition 6
covid-19 3
crime 3
culture 1
dental 1
diabetes 8
disease 3
economy 1
genetics 8
heart 5
immune 5
kidneys 5
language 1
metabolism 1
misc 1
nutrition 5
pain 3
physical 3
politics 3
pollution 1
practice 3
privacy 5
psychology 8
reproduction 4
rights 2
sleep 1
unk
war-confl
 
Scanned: 2683
Evaluated: 284
Selected: 75

 
    AGING    DIABETES    KIDNEYS    METABOLISM   

Mcr13-024

Association of Modified Cardiometabolic Index with Cardiovascular-Kidney-Metabolic Syndrome Staging, All-Cause Mortality, and Cardiovascular Mortality: A Population-Based Cohort Study

Quote:Objective To investigate the association of the modified cardiometabolic index MCMI with cardiovascular-kidney-metabolic CKM syndrome staging, all-cause and cardiovascular mortality, and compare its predictive performance with traditional indices. ... Conclusions MCMI is an independent predictor of CKM progression and mortality. Its cardiovascular mortality risk is predominantly mediated by diabetes.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.30.26349722v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.30.26349722v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Yuqi Qin, Yibo Yan, 
    PRIME    AGING    COGNITION    GENETICS   

Mge13-012

Genetic and epigenetic regulation of SLC6A4 shapes vulnerability to cognitive decline and depressive tendency in later life

Quote:DNA methylation at a functional promoter CpG site increased with age and partially mediated age-related cognitive decline specifically among low-activity genotypes. In contrast, the high-activity genotype was associated with relative resistance to these functional declines, partly mediated by a protective effect on hippocampal volume during aging. Notably, genotype-dependent effects on hippocampal volume were absent in adolescence, indicating that the influence of SLC6A4 emerges in an aging-specific manner. Together, these findings identify SLC6A4 promoter activity as a key genetic factor modulating vulnerability and resilience in later life.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.26.26349121v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.26.26349121v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: The+Japan+Prospective+Studies+Collaboration+for+Aging+and+Dementia+(JPSC-AD)+study+group&t=50" TARGET=auth>Yutaro Yanagida, Yutaka Nakachi, Naoto Kajitani, Satoshi Kikkawa, Tempei Ikegame, Shinsuke Koike, Norihide Maikusa, Naohiro Okada, Izumi Naka, Jun Ohashi, Hiroko Sugawara, Kazuhiro Yoshiura, Ayaka Fujii, Emi Kiyota, Risa Watanabe, Yui Murata, Yasuyuki Taki, Yasuko Tatewaki, Benjamin Thyreau, Yuji Takano, Manabu Makinodan, Norio Sakai, Tomohisa Ishikawa, Yosuke Hidaka, Mamoru Hashimoto, Yoshihiko Furuta, Tomoyuki Ohara, Toshiharu Ninomiya, Kiyoto Kasai, Minoru Takebayashi, Miki Bundo, Kazuya Iwamoto, span class="nlm-collab" data-hwp-id="collab-1">The Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) study group, 
    AGING    IMMUNE   

Min13-038

Streptococcus agalactiae, a frequent but not so well-known cause of bone and joint infections: a Multicentric observational study 2014-23

Quote:Conclusion S. agalactiae emerges as a prominent and distinct pathogen in complex streptococcal BJIs, with specific risk factors such as arteriopathy, obesity and diabetes mellitus, and more chronic infections.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.30.26349534v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.30.26349534v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Simon Jamard, gwenael Le Moal, chloe Plouzeau-Jayle, Cedric Arvieux, Sophie Ressier, raphael Lecomte, Stephane Corvec, Severine Ansart, Claudie Lamoureux, Pierre Abgueguen, Rachel Chenouard, Marie Frederique Lartigue, Adrien Lemaignen, 
    AGING    LANGUAGE   

Mne13-010

Cognitive and brain reserve in bilingual speakers with clinical AD variants

Quote:Cognitive performance in monolinguals and bilinguals was comparable within variants. DISCUSSION: Bilingualism may support cognitive reserve preserved cognition despite reduced GMV in both AD variants, with additional brain reserve in lvPPA.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.27.26349575v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.27.26349575v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Nicoletta Biondo, John Matthew Suntay, Muskaan Sandhu, Jeanine Sandra Estaban, Janhavi Pillai, Maria Luisa Mandelli, Eugenie Mamuyac, Rochelle-Jan Dionisio Reyes, Ariel Guevarra, Maya L Henry, Nina F. Dronkers, Stephanie Grasso, Jessica de Leon, 
    AGING    BRAIN   

Mne13-012

Predicting long term clinical outcomes in Parkinsons Disease using short term rating scales

Quote:Conclusions: We have demonstrated how a treatment effect in a trial specified in terms of a progression change of a rating scale can be contextualised into a long-term reduction in the probability of clinically relevant milestones.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.27.26349548v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.27.26349548v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Matthew Burnell, Cristina Gonzalez-Robles, Marie-Louise Zeissler, Michele Bartlett, Caroline S Clarke, Carl Counsell, Michele T Hu, Tom Foltynie, Camille Carroll, Michael Lawton, Yoav Ben-Shlomo, James Carpenter, 
    AGING    GENETICS   

Mne13-016

Bridging Genetics and Precision Medicine in Parkinsons Disease through GP2

Quote:GP2s unified framework supports equitable recruitment for gene-targeted therapeutic studies and helps address critical gaps in Parkinsons disease genetics and future therapeutic development.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.26.26349418v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.26.26349418v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: the+Global+Parkinson's+Genetics+Program+(GP2)&t=50" TARGET=auth>Kajsa Atterling Brolin, Lara M Lange, Emily Navarro-Jones, Simona Jasaityte, Yuan Ye Beh, Zih-Hua Fang, Hirotaka Iwaki, Lietsel Jones, Christine Klein, Teresa Kleinz, Hampton L Leonard, Ignacio Mata, Alastair Noyce, Njideka U Okubadejo, Paula Saffie Awad, Laurel Screven, Ai Huey Tan, Marco Toffoli, Dan Vitale, Andrew Singleton, Cornelis Blauwendraat, Mike A Nalls, Huw Morris, span class="nlm-collab" data-hwp-id="collab-1">the Global Parkinson's Genetics Program (GP2), 
    AGING    BRAIN   

Mne13-018

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease

Abstract: https://www.medrxiv.org/content/10.64898/2026.03.26.26349399v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.26.26349399v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: S. A. Lorkiewicz, C. Abdelnour, M. Bolen, A. M. Smith, M. Shahid-Besanti, D. Hemachandra, E. M. Müller-Oehring, N. Siddiqui, L. Montoliu-Gaya, B. Arslan, N. J. Ashton, E. N. Wilson, L. Tian, K. I. Andreasson, E. C. Mormino, V. W. Henderson, H. Zetterberg, K. L Poston, 
    AGING    BRAIN   

Mne13-022

Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimers Disease

Quote:INTERPRETATION: Our results suggest that the main CSF proteomic landscape changes in ADAD are due to the presence of a pathogenic mutation and occur prior to symptom onset. Improved performance of multi-protein composite to predict EYO compared to single biomarker values highlights the added value of multiplex proteomic signatures for biomarker panel development.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.31.26349851v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.31.26349851v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Wenjing Lin, Aleksandra Beric, Julie K Wisch, Bryce Baker, Gina Jerome, Matthew Minton, Sam Preminger, Jennifer Stauber, Suzanne E Schindler, Jeff Dage, Ricardo Allegri, David Aguillon, Tammie Benzinger, Jasmeer Chhatwal, Alisha Daniels, Gregory Day, Emma Devenney, Nick Fox, Alison Goate, Brian Gordon, Jason Hassenstab, Edward Huey, Takeshi Ikeuchi, Suman Jayadev, Mathias Jucker, Takanobu Ishiguro, Jae-Hong Lee, Allan Levey, Johannes Levin, John C Morris, Richard Perrin, Alan Renton, Jee Hoon Roh, Chengjie Xiong, Randall J Bateman, Beau Ances, Carlos Cruchaga, Celeste Karch, Charlene Supnet-Bell, Jorge J Llibre-Guerra, Eric McDade, Laura Ibanez, 
    AGING    BRAIN   

Mne13-024

NeuroFM: Toward Precision Neuroimaging with Foundation Models for Individualized Brain Health Estimation

Quote:Evaluated on 136,361 multi-cohort volumes, NeuroFM generalizes across domains and enables individual-level brain health profiling, estimating future dementia risk years before diagnosis. Together, these findings establish a disease-naive foundation model for precision neuroimaging with potential to support quantitative brain health assessments across settings.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.27.26349489v2
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.27.26349489v2.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Austin Dibble, Connor Dalby, Michele Sevegnani, Alessio Fracasso, Donald M Lyall, Monika Harvey, Michele Svanera, 
    AGING    DISEASE   

Mne13-028

Design-induced artifacts when disease clocks are plugged into second-stage analyses of symptom onset

Quote:Conclusion: The apparent predictive ability of plasma p-tau217 disease clocks is driven largely by structural age relationships rather than independent biomarker signal.
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.26.26349230v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.26.26349230v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Philip Insel, Michael C Donohue, 
    AGING    NUTRITION   

Mnu13-026

Ultra-processed food consumption and frailty in older adults: a systematic review and meta-analysis

Quote:Meta-analysis showed that higher consumption of UPFs was significantly associated with an increased risk of frailty
Abstract: https://www.medrxiv.org/content/10.64898/2026.03.29.26349639v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.03.29.26349639v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Min Pu, Qianying Ma, 
    PRIME    AGING    COGNITION   

Zzb13-000

Is Methylene Blue the Secret Weapon for Fighting Alzheimers and Keeping Your Brain Young?

Comment: Works for some peoople, others say they have not had much success with it. there are some interesting youtube videos on the subject.
Article: https://www.thegatewaypundit.com/2026/03/is-methylene-blue-secret-weapon-fighting-alzheimers-keeping-17/
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 

  Javilk's Research Links for Week 13
Updated 04/04/2026-01:13:07 AM
What interests you? What have you found? Tell me!
Drop me a note to subscribe or submit something.